The Latest Breaking News from EMA

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on Friday recommending Eli Lilly and Co.’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease in adults with confirmed amyloid pathology who are apolipoprotein E ε4 (ApoE4) heterozygotes or non-carriers.

Inhalers may be small, but they can make a big impact on the environment.

Interpol cited a concerning rise in demand for unauthorised weight loss drugs and peptide supplements in Europe and other wealthy regions.

Rowe BMW took Nurburgring 24 Hours victory after a penalty for the leading Manthey EMA Porsche following a clash, which meant that victory went to Raffaele Marciello, Kelvin van der Linde, Jesse Krohn and Augusto Farfus.

Rowe BMW took Nurburgring 24 Hours victory after a penalty for the leading Manthey EMA Porsche following a clash, which meant that victory went to Raffaele Marciello, Kelvin van der Linde, Jesse Krohn and Augusto Farfus.

Harare, the capital of Zimbabwe, is fast becoming a key player in the battle against climate change, developing innovative approaches to tackle waste management, restore degraded ecosystems, and promote sustainable urban planning. Like many other cities across the globe, Harare faces significant environmental challenges - yet it is also a…

The medicine will remain on the shelves but will come with additional warnings about the side effects, which appear to be rare.

Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU's radiopharmaceutical sector, according to the European Medicines Agency (EMA).

The company behind the drug donanemab said it will ask regulators to reconsider the decision.